Ageing is a natural and unavoidable phenomenon that brings with it various health challenges, including arthritis, memory ...

STEM Potential supports you through years 10 and 12 with insightful lectures, subject-specific workshops and a non-residential summer school. STEM Potential is a multi-year programme of activities and ...

Objective To investigate if treatment with a single injection of autologous micro-fragmented adipose tissue improved the patient-reported health compared to a placebo saline injection in patients ...

Treatment for CLL continues to change. Doctors are using newer targeted cancer drugs. This means a stem cell transplant is now a less common treatment for CLL. You have a transplant using donor cells ...

Dr Tsun Sean Law details the ARISE trials and outlines other orthobiologic treatments currently available — but not yet reimbursable — for osteoarthritis.

According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.

1 Department of Rheumatology and Immunology, Qinzhou First People's Hospital, Qinzhou, Guangxi, China 2 Minda Hospital of Hubei Minzu University, Enshi, China Cell therapy is an emerging strategy for ...

Renal fibrosis is one of the main pathological features of chronic kidney disease (CKD), and its treatment has been a hot research topic. Recent studies have shown that stem cell therapy can repair ...

When the researchers monitored the metabolic rates of the Klf15 knockout mice they observed that these mice burned more energy compared to controls. “Rather than targeting the stem cells, targeting ...

1 Despite several treatment options, including approved thrombopoietin receptor agonists and commonly used antibody-reducing approaches—such as B-cell depletion with the anti-CD20 monoclonal antibody ...

Only a few patients have undergone an intensive gene therapy cure for sickle cell disease since it was approved by the FDA due to it's high cost and limited access.